Office-based Adoption The product is designed for office-based, non-surgical treatment of bladder disorders, making it a fit for outpatient urology and urogynecology clinics. Focus sales messaging on minimal anesthesia, no major procedure changes, and reversibility. Offer turnkey adoption kits including device supply, clinician training, patient education materials, and post-sale service agreements.

Channel Partnerships With a small team, Solace could scale through medical device distributors, OEM collaborations, or contract manufacturing and service partners. Establish regional distributors, target ambulatory surgical centers, and integrate with existing pelvic health product ecosystems.

Reimbursement Readiness The office-based, less invasive nature suggests potential cost savings versus drug therapies or surgical options. Develop ROI models and payer value dossiers to support reimbursement and faster adoption. Support data collection protocols to generate real-world outcomes.

Marketing Enablement Leverage the existing web analytics setup to drive awareness and lead generation among clinics and patients. Offer digital marketing support, educator-led assets, and CRM-ready patient education content to accelerate clinician engagement and program enrollment.

Regional Focus Headquartered in Massachusetts with a small team, presenting opportunities to target Northeast health systems and academic centers for early pilots. Emphasize differentiators such as office-based, anesthesia-free, reversible therapy to stand out against larger competitors.